It is probably reasonable enough by now to talk about the Drug launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again. The marketing landscape is dynamic as ever, more so with communication routes evolving at lightning speed and […]
